HUM vs RLAY · P/E 39, rev $117.76B vs rev $10.0M
Humana Inc (HUM) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the HUM and RLAY stock pages for the full models.
Not investment advice.